M. Riska, H. Haryati, E. Suhartono, and T. A. . Wanahari, “Prognostic Value of the Systemic Immune-Inflammation Index in EGFR Mutation-Positive Lung Adenocarcinoma Patients Treated with Tyrosine Kinase Inhibitors”, JR, vol. 8, no. 3, pp. 133–139, Sep. 2022.